Entero Healthcare Solutions Limited

As of June 30, 2026, Entero Healthcare Solutions Limited carries a market capitalization of 51.60B, placing it among publicly traded companies globally. Its enterprise value stands at 51.60B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Entero Healthcare Solutions Limited's next confirmed earnings release is scheduled for November 18, 2026.

As of June 30, 2026, Entero Healthcare Solutions Limited has 43.52M shares outstanding.

As of June 30, 2026, Entero Healthcare Solutions Limited trades at a trailing price-to-earnings ratio of 41.14.

As of June 30, 2026, Entero Healthcare Solutions Limited trades at an EV/EBITDA multiple of 16.94 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.72 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 20.00 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 51.60B versus a market cap of 51.60B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 15.45M in revenue per employee across its workforce of 4,614.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Entero Healthcare Solutions Limited recorded 424.34M in income tax expense. That works out to an effective tax rate of 20.20, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 2.10B, leaving 1.25B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Entero Healthcare Solutions Limited's stock has gained approximately 33.40% over the past 52 weeks. The 50-day moving average sits at 1,667.48, while the 200-day moving average is 1,295.39.

Over the twelve months ended June 30, 2026, Entero Healthcare Solutions Limited generated 71.28B in revenue and converted that into 1.25B in net income, yielding earnings per share of 38.48. EBITDA reached 3.05B, while operating income came in at 2.66B.

Over the twelve months ended June 30, 2026, Entero Healthcare Solutions Limited posted a gross margin of 10.69, reflecting its pricing power and cost economics. The operating margin of 3.73 and net profit margin of 1.76 provide insight into operational efficiency.